Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
Bio-Techne (NASDAQ: TECH) will host a conference call and webcast on Wednesday, February 4, 2026 at 8:00 a.m. CST to review second quarter fiscal 2026 financial results.
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) will host a conference call and webcast on Wednesday, February 4, 2026 at 8:00 a.m. CST to review second quarter fiscal 2026 financial results.
Live access: dial 1-800-579-2543 or 1-785-424-1789 (international) using Conference ID TECHQ2, or join the webcast at https://investors.bio-techne.com/ir-calendar. A recorded rebroadcast will be available from 11:00 a.m. CST on Feb 4, 2026 through 11:00 p.m. CST on Mar 4, 2026 by dialing 1-844-512-2921 or 1-412-317-6671 and referencing Conference ID 11160826.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TECH
In the Jan 20 session, TECH gained 1.30%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Current price
- $68.67
- Pre‑announcement trading level for TECH
- Relative volume
- 1.83x
- Volume 3,481,356 vs 20‑day average 1,897,709
- Q1 FY2026 net sales
- $286.6M
- From 10‑Q filed on Nov 5, 2025
- Q1 FY2026 diluted EPS
- $0.24
- Up from $0.21 year over year
- Q1 FY2026 gross margin
- 65.6%
- Improved from 63.2% year over year
- Q1 FY2026 operating income
- $47.7M
- Up from $40.0M year over year
- Long‑term debt
- $300.0M
- Down from $346.0M after $46.0M repayments
- Earnings call time
- 8:00 a.m. CST, Feb 4, 2026
- Scheduled Q2 FY2026 results conference call
Historical Context
-
Announced CEO presentation at 2026 J.P. Morgan Healthcare Conference.
-
Partnered with Wyss Center to advance automated 3D multiomics workflows.
-
Launched enhanced Leo System for high‑throughput, multiplexed protein analysis.
-
Planned presentations at three December 2025 healthcare investor conferences.
-
Licensed AI‑designed NovoBody Duo molecules to expand protein portfolio.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Access to the discussion may be obtained as follows:
Time: | 8:00 a.m. CST |
Date: | February 4, 2026 |
Dial-in: | 1-800-579-2543 or 1-785-424-1789 (for international callers) |
Conference ID: | TECHQ2 |
Webcast: |
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11160826.
The replay will be available from 11:00 a.m. CST on Wednesday, February 4, 2026, until 11:00 p.m. CST on Wednesday, March 4, 2026.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over
Contact: | David Clair, Vice President, Investor Relations |
612-656-4416 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-february-4-2026-to-announce-second-quarter-fiscal-2026-financial-results-302663784.html
SOURCE Bio-Techne Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.